Eosinophilic pneumonia historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu) |
||
Line 1: | Line 1: | ||
{{Eosinophilic pneumonia}} | {{Eosinophilic pneumonia}} | ||
'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto: | '''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh@perfuse.org] | ||
==Overview== | ==Overview== | ||
Chronic eosinophilic pneumonia was first described by Carrington in [[1969]], and it is also known as '''Carrington syndrome'''. Prior to that, eosinophilic pneumonia was a well described pathologic entity usually associated with medication or parasite exposures. Acute eosinophilic pneumonia was first described in [[1989]]{{ref|Badesch}}{{ref|Allen}}. | Chronic eosinophilic pneumonia was first described by Carrington in [[1969]], and it is also known as '''Carrington syndrome'''. Prior to that, eosinophilic pneumonia was a well described pathologic entity usually associated with medication or parasite exposures. Acute eosinophilic pneumonia was first described in [[1989]]{{ref|Badesch}}{{ref|Allen}}. |
Revision as of 16:22, 1 November 2012
Eosinophilic pneumonia Microchapters |
Diagnosis |
Treatment |
Case Studies |
Eosinophilic pneumonia historical perspective On the Web |
American Roentgen Ray Society Images of Eosinophilic pneumonia historical perspective |
Risk calculators and risk factors for Eosinophilic pneumonia historical perspective |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Overview
Chronic eosinophilic pneumonia was first described by Carrington in 1969, and it is also known as Carrington syndrome. Prior to that, eosinophilic pneumonia was a well described pathologic entity usually associated with medication or parasite exposures. Acute eosinophilic pneumonia was first described in 1989[3][4].